Nebulized Resveratrol Plus Carboxymethyl-β-Glucan for Reducing IL-5 in Children With Allergic Rhinitis
Clinical trial NCT03349619 · COMPLETED
Trial details
- NCT number
- NCT03349619
- Sponsor
- Istituto per la Ricerca e l'Innovazione Biomedica
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-05
- Primary completion
- 2018-07-31
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.